CRMD - CorMedix Inc.
About CorMedix Inc. (https://www.cormedix.com)
CorMedix Inc. is a biopharmaceutical company engaged in the development and commercialization of medical treatments for the prevention and care of infectious and inflammatory conditions, serving markets both in the United States and internationally. Its leading product candidate, DefenCath/Neutrolin, represents a novel anti-infective solution. This treatment aims to diminish and avert catheter-related infections and blood clots in patients who utilize central venous catheters for medical procedures such as hemodialysis, total parenteral nutrition, and oncology care. Incorporated in 2006, the company initially operated as Picton Holding Company, Inc. until officially adopting the name CorMedix Inc. in January 2007. Its corporate headquarters are located in Berkeley Heights, New Jersey.
Key Executives
| NAME | TITLE | DOB | SALARY |
|---|---|---|---|
| Joseph Todisco | CEO & Chairman of the Board of Directors | 1976 | $1,608,676 USD |
| Kaufman Beth Zelnick | EVP, Chief Legal and Compliance Officer & Corporate Secretary | 1961 | $981,592 USD |
| Elizabeth Hurlburt | Executive Vice President, Chief Operating Officer & Chief Integration Officer | 1979 | $959,370 USD |
| Matthew T. David | EVP & Chief Business Officer | 1978 | $634,855 USD |
| Susan Blum | Executive Vice President & Chief Financial Officer | 1973 | $634,855 USD |
| Michael Seckler | Executive Vice President & Chief Commercial Officer | 1966 | $561,571 USD |
| Beth Steinbrenner | SVP & Chief Human Resource Officer | – | – |
| Donna Ucci | Senior Vice President & Head of Global Quality | – | – |
| Peter Sullivan BCOP | Senior Vice President of Market Access | – | – |
| Tushar Mukherjee | Senior Vice President & Head of Technical Operations | – | – |